FUNDAMENTALS · Fundamentals · US Healthcare

Dyadic International (DYAI) Fundamentals 2026 — Revenue Analysis | SniperIQ

Dyadic International (DYAI) is a US-listed Healthcare company in Biotechnology with a market capitalization of $48M, trading at

.31 on the NASDAQ. This SniperIQ fundamentals page covers Dyadic International's valuation, profitability (net margin -245.1%), revenue (
M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$48M
Net Margin-245.1%
Revenue (FY25)
M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Dyadic International's market cap?

Dyadic International (DYAI) has a market capitalization of approximately $48M, trading at

.31 on the NASDAQ. Market cap moves with the live share price.

How profitable is Dyadic International?

Dyadic International runs a net profit margin of -245.1%, a gross margin of 31.3%, and an operating margin of -238.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Dyadic International generate?

Dyadic International reported revenue of

M for fiscal year 2025, with net income of -$7M and earnings per share (EPS) of -0.23. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Dyadic International pay a dividend?

Dyadic International does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Dyadic International financially healthy?

Dyadic International carries a debt-to-equity ratio of -12.39x and a current ratio of 2.42x, with a market beta of 1.15. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Dyadic International a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dyadic International (DYAI) the key facts are: market cap $48M, revenue

M, 52-week range 0.65-1.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Dyadic International's full fundamentals live

Get Dyadic International's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: eXoZymes (EXOZ) fundamentals · Metagenomi, Inc. Common Stock (MGX) fundamentals · Mereo BioPharma Group (MREO) fundamentals · Filana Therapeutics (FLNA) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons